For instance, several studies have shown that telmisartan, an angiotensin receptor blocker (ARB) and partial agonist of peroxisome proliferator-activated receptorgamma (PPAR-γ), can reduce blood pressure as well as improve insulin resistance in obese subjects[10]-[12]. This evidence concerns the gene PPARG and Insulin resistance.